Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3851/IMP1730 http://scihub22266oqcxt.onion/10.3851/IMP1730 C4907367!4907367!21447860     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Antivir+Ther 2011 ; 16 (2): 123-35 Nephropedia Template TP {{tp|p=21447860|t=2011. Preventing and treating secondary bacterial infections with antiviral agents |pdf=|usr=}}{{21447860}} gab.com Text Preventing and treating secondary bacterial infections with antiviral agents JO: Antivir Ther http://www.kidney.de/pget.php?&tw=1&pmid=21447860 #FOAvip Bacterial super-infections contribute to the significant morbidity and mortality associated with influenza and other respiratory virus infections. There are robust animal model data but only limited clinical information on the effectiveness of licensed antiviral agents for the treatment of bacterial complications of influenza. The association of secondary bacterial pathogens with fatal pneumonia during the recent H1N1 influenza pandemic highlights the need for new development in this area. Basic and clinical research into viral-bacterial interactions over the last decade has revealed several mechanisms that underlie this synergism. By applying these insights to antiviral drug development, the potential exists to improve outcomes by means other than direct inhibition of the virus. Twit Text FOAVip Preventing and treating secondary bacterial infections with antiviral agents ????Antivir Ther http://www.kidney.de/pget.php?&tw=1&pmid=21447860 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=21447860 #FOAvip English Wikipedia <ref>{{Cite pmid|21447860}}</ref> Preventing and treating secondary bacterial infections with antiviral agents #MMPMID21447860 McCullers JA Antivir Ther 2011[]; 16 (2): 123-35 PMID21447860show ga Bacterial super-infections contribute to the significant morbidity and mortality associated with influenza and other respiratory virus infections. There are robust animal model data but only limited clinical information on the effectiveness of licensed antiviral agents for the treatment of bacterial complications of influenza. The association of secondary bacterial pathogens with fatal pneumonia during the recent H1N1 influenza pandemic highlights the need for new development in this area. Basic and clinical research into viral-bacterial interactions over the last decade has revealed several mechanisms that underlie this synergism. By applying these insights to antiviral drug development, the potential exists to improve outcomes by means other than direct inhibition of the virus. äPreventing and treating secondary bacterial infections with antiviral (epmc).pdf DeepDyve Pubget Overpricing